TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.41 0.01 (3.7%) 0.0 (0.0%) 0.01 (1.82%) 0.01 (3.7%) --- --- 0.01 (3.7%) 0.01 (3.7%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.2177
Diluted P/E:
-0.2177
RSI(14) 1m:
59.22
VWAP:
0.42
RVol:
0.0047

Events

Period Kind Movement Occurred At
10m Price increase 10m 0.67 +0.03 (+4.1%) Oct 16 07:40
1m Price increase 1m 0.67 +0.03 (+4.1%) Oct 16 07:40
1m Price increase 1m 0.64 +0.01 (+1.18%) Oct 16 07:35
1m Price increase 1m 0.64 +0.01 (+1.0%) Oct 16 07:34
1m Price decrease 1m 0.63 -0.01 (-1.81%) Oct 16 07:31

Related News